Company profile
Decibel Cannabis Company Inc.
OTC: DBCCF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Calgary, ABReports USD
#374 of 1,422 Healthcare companies by revenue65th-percentile growth
EA Score
62CFH 63DQ —GM 61SS 55
v0.1 · 45/100 weight · provisional
↑ return on assets, return on equity · ↓ Piotroski F, listing tenure
Methodology →Revenue TTM
$92.0M
Rev growth YoY (TTM)
+27.6%
Net income (FY)
-$2.1M
Employees
171
as of 2026-08-19
Market cap
$50.0M
as of 2026-08-19
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$80.6M112.6M CAD2025
Net income-$2.1M-2.9M CAD2025
Operating income-$12.4M-17.4M CAD2025
Total assets$103.2M141.5M CAD2025
Liabilities$57.8M79.2M CAD2025
Equity$45.5M62.3M CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Decibel Cannabis Company Inc.’s revenue?
Decibel Cannabis Company Inc. booked $80.6M in FY2025 revenue, growing 19% year over year — faster than most Healthcare companies we track, at a -2.6% net margin.
Peers · Healthcare
IRadimed Corporation86AArcturus Therapeutics Holdings Inc.49DMeiraGTx Holdings plc48DTELA Bio, Inc.47DEton Pharmaceuticals, Inc.60CVitalhub Corp.77B+Key facts
CEOBenjamin Sze
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersCalgary, AB
ExchangeOTC: DBCCF
Employees171
IPO date2019-01-09
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.